
Boutique Venture Partners is a science-first, founder-focused venture capital firm investing in early-stage healthcare, life sciences, and frontier technology companies. Founded in 2020 and based in Palo Alto, California, the firm partners with authentic founders to create innovative approaches that improve human and planetary health.
38% of their portfolio is in Healthcare. Deal activity increased 150% year-over-year (5 deals in the last 12 months). Their most common stage is series-a (54% of deals). Average disclosed round size is $20.7M (across 20 rounds with reported amounts).
Portfolio
18
Fund Size
—
Top Stage
Series A
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
24 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| KKanvas | Series A | $48M | May 2026 |
| Series A | $14.2M | Feb 2026 | |
| Series A | $14.2M | Feb 2026 | |
| Series A | $30M | Jan 2026 | |
| Bridge | $5.2M | Oct 2025 | |
| Series A | $17M | Jan 2025 | |
| DDelfina Care | Series A | — | Jan 2025 |
| Series A | $12.5M | Jul 2024 | |
| Seed | $2.5M | Apr 2024 | |
| Seed | $2.5M | Apr 2024 | |
| Seed | $2.5M | Apr 2024 | |
| Series A | — | Nov 2023 | |
| FFluidAI | Series A | $15M | Oct 2023 |
| Series B | $60M | Aug 2023 | |
| Series A | $6.1M | Jul 2023 | |
| ZZeda | Series B | $52M | Mar 2023 |
| PPrinterPrezz | Series B | $52M | Mar 2023 |
| NNerv Technology | Series A | — | Jan 2023 |
| ZZeda | Series B | $52M | Jan 2023 |
| Pre-Seed | $2.2M | Mar 2022 | |
| NNerv Technology | Seed | — | Apr 2021 |
| Seed | $5.7M | Jan 2021 | |
| PPrinterPrezz | Series A | $16M | Dec 2020 |
| Series A | $4M | — |
Top Co-Investors
Graphene Ventures5 shared
Mucker Capital5 shared
Riverfront Ventures5 shared
Techstars4 shared
Tau Ventures3 shared
Plug and Play Tech Center3 shared
Everywhere Ventures3 shared
Y Combinator3 shared
Gaingels3 shared
SOSV3 shared
Alumni Ventures3 shared
Berkeley Catalyst Fund3 shared
Goodwater Capital2 shared
Metrodora Ventures2 shared
Mayo Clinic2 shared
U.S. Venture Partners2 shared
Bread & Butter Ventures2 shared
Tokio Marine Future Fund2 shared
Story Ventures2 shared
SemperVirens Venture Capital2 shared
Last updated: 20 October 2026